ADIPOQ and type 2 diabetes mellitus: Although restricted prior studies investigated the linkage between the aforementioned adiponectin SNPs and the DPN risk29–31, the available inadequate documents and the unpredictable outcomes from these reports encouraged us toward considering a systematic and regular investigation of the adiponectin SNPs for their impact on the risk of DPN in T2DM patients.